He Qin - Net Worth and Insider Trading
He Qin Net Worth
The estimated net worth of He Qin is at least $28 Million dollars as of 2025-04-13. He Qin is the Director of KPC Pharmaceuticals Inc and owns about 1,616,014 shares of KPC Pharmaceuticals Inc (SHSE:600422) stock worth over $28 Million. Details can be seen in He Qin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that He Qin has not made any transactions after 2017-01-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of He Qin
He Qin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, He Qin owns 1 companies in total, including KPC Pharmaceuticals Inc (SHSE:600422) .
Click here to see the complete history of He Qin’s form 4 insider trades.
Insider Ownership Summary of He Qin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600422 | KPC Pharmaceuticals Inc | 2017-01-23 | Director |
He Qin Latest Holdings Summary
He Qin currently owns a total of 1 stock. He Qin owns 1,616,014 shares of KPC Pharmaceuticals Inc (SHSE:600422) as of January 23, 2017, with a value of $28 Million.
Latest Holdings of He Qin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600422 | KPC Pharmaceuticals Inc | 2017-01-23 | 1,616,014 | 17.28 | 27,924,722 |
Holding Weightings of He Qin
He Qin Form 4 Trading Tracker
According to the SEC Form 4 filings, He Qin has made a total of 0 transactions in KPC Pharmaceuticals Inc (SHSE:600422) over the past 5 years. The most-recent trade in KPC Pharmaceuticals Inc is the sale of 175,400 shares on January 23, 2017, which brought He Qin around $2 Million.
Insider Trading History of He Qin
- 1
He Qin Trading Performance
GuruFocus tracks the stock performance after each of He Qin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by He Qin is 8.81%. GuruFocus also compares He Qin's trading performance to market benchmark return within the same time period. The performance of stocks bought by He Qin within 3 months outperforms 10 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how He Qin's insider trading performs compared to the benchmark.
Performance of He Qin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.84 | | | | | |
| Relative Return to S&P 500(%) | 5.56 | | | | | |
He Qin Ownership Network
Ownership Network List of He Qin
Ownership Network Relation of He Qin
He Qin Owned Company Details
What does KPC Pharmaceuticals Inc do?
Who are the key executives at KPC Pharmaceuticals Inc?
He Qin is the Director of KPC Pharmaceuticals Inc. Other key executives at KPC Pharmaceuticals Inc include senior management Qu Xiao Ru , senior management Xie Bo , and senior management Meng Li .
KPC Pharmaceuticals Inc (SHSE:600422) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
KPC Pharmaceuticals Inc (SHSE:600422)'s detailed insider trading history can be found in Insider Trading Tracker table.
KPC Pharmaceuticals Inc Insider Transactions
He Qin Mailing Address
Above is the net worth, insider trading, and ownership report for He Qin. Currently GuruFocus does not have mailing address information for He Qin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
